Staging, Surgery, and Emerging Targeted Strategies in Chondrosarcoma: Your Key Clinical Questions Answered

On International Chondrosarcoma Awareness Day, OncLive sat down with Philippos Costa, MD; and Hari Deshpande, MD, to discuss frequently asked questions (FAQ) about the complexities of chondrosarcoma management. The following FAQ, adapted from their conversation, provide clinical insights into chondrosarcoma staging, diagnosis, and disease biology; the importance of surgery as the primary treatment for localized chondrosarcoma; and the potential role for IDH1-targeted therapy and DR5 agonists in this rare disease subtype.